A Bayesian weighted quasi-likelihood design for phase I/II clinical trial with repeated dose administration in preterm newborns

被引：0
|
作者：
Ursino, Moreno [1 ]
Yuan, Ying [2 ]
Alberti, Corinne [3 ]
Comets, Emmanuelle [4 ,5 ]
Friede, Tim [6 ]
Lents, Frederike [7 ]
Stallard, Nigel [8 ]
Zohar, Sarah [1 ]
机构：
[1] INSERM, UMRS1138, Team22, Paris, France
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] INSERM, UMR 1123, Paris, France
[4] INSERM, CIC 1414, Paris, France
[5] INSERM IAME, UMR 1137, Paris, France
[6] Univ Med Ctr Gottingen, Gottingen, Germany
[7] Fed Inst Drugs & Med Devices, Bonn, Germany
[8] Univ Warwick, Warwick Med Sch, Warwick, England
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
P343
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bayesian dose-finding phase I trial design incorporating pharmacokinetic assessment in the field of oncology
    Takeda, Kentaro
    Komatsu, Kanji
    Morita, Satoshi
    PHARMACEUTICAL STATISTICS, 2018, 17 (06) : 725 - 733
  • [32] Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trials
    Yin, Jun
    Yuan, Ying
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (06) : 1006 - 1025
  • [33] A Bayesian pharmacokinetics integrated phase I-II design to optimize dose-schedule regimes
    Lu, Mengyi
    Yuan, Ying
    Liu, Suyu
    BIOSTATISTICS, 2024, 26 (01)
  • [34] A Bayesian pharmacokinetics integrated phase I-II design to optimize dose-schedule regimes
    Lu, Mengyi
    Yuan, Ying
    Liu, Suyu
    BIOSTATISTICS, 2024, 26 (01)
  • [35] Dose-schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation
    Li, Yisheng
    Bekele, B. Nebiyou
    Ji, Yuan
    Cook, John D.
    STATISTICS IN MEDICINE, 2008, 27 (24) : 4895 - 4913
  • [36] A dose-schedule finding design for phase I-II clinical trials
    Guo, Beibei
    Li, Yisheng
    Yuan, Ying
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2016, 65 (02) : 259 - 272
  • [37] Phase I/II clinical trial of immunotherapy by intratumoral administration of dendritic cells for patients with melanoma
    Saito, Masataka
    Fujita, Tomonobu
    Tanikawa, Akiko
    Ishida, Akaru
    Sakurai, Toshiharu
    Handa, Makoto
    Amagai, Masayuki
    Kawakami, Yutaka
    PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (02) : 328 - 328
  • [38] A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
    Thygesen, Helene
    Dragalin, Vladimir
    Whitehead, Anne
    Whitehead, John
    PHARMACEUTICAL STATISTICS, 2012, 11 (06) : 476 - 484
  • [39] A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial
    Bekele, BN
    Shen, Y
    BIOMETRICS, 2005, 61 (02) : 344 - 354
  • [40] A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines
    Cunanan, Kristen M.
    Koopmeiners, Joseph S.
    STATISTICS IN MEDICINE, 2017, 36 (01) : 43 - 53
12345